Author

J. Bermeo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:bulk RNA-seq· 2 Approach:statistical model· 2 Assay:ATAC-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1

Frequent Co-Authors

C. A. Iacobuzio-Donahue· 2 shared A. Cardenas· 1 shared A. L. Massa· 1 shared A. Luthra· 1 shared A. Mahmoud· 1 shared A. Moorman· 1 shared A. P. Makohon-Moore· 1 shared A. Saxena· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

C. A. Iacobuzio-Donahue

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Progressive plasticity during colorectal cancer metastasis

A. Moorman, F. Cambuli, E. Benitez, Q. Jiang, Y. Xie, A. Mahmoud, M. Lumish, S. Hartner, S. Balkaran, J. Bermeo, S. Asawa, C. Firat, A. Saxena, A. Luthra, V. Sgambati, , K. Ganesh

This study identifies progressive plasticity in colorectal cancer metastases, showing reprogramming into fetal progenitor states and divergent differentiation, linked to poor survival.

bioRxiv · Aug 18, 2023Cancer Biology

MYC controls metastatic heterogeneity in pancreatic cancer

R. Maddipati, R. Norgard, T. Baslan, K. Rathi, A. Zhang, P. Raman, J. Pitarresi, M. Wengyn, T. Yamazoe, J. Li, D. Balli, M. LaRiviere, I. Folkert, I. Millstein, J. Bermeo, , B. Stanger

This study identifies MYC as a key driver of metastatic heterogeneity in pancreatic cancer by linking its activity to increased metastasis through TAM recruitment.

bioRxiv · Jan 30, 2021 · PreprintCancer Biology

Pancreatic cancer prognosis is predicted by a novel ATAC-array technology for assessing chromatin accessibility

S. Dhara, S. Chhangawala, H. Chintalapudi, G. Askan, V. Aveson, A. L. Massa, L. Zhang, A. P. Makohon-Moore, N. Lecomte, J. P. Melchor, J. Bermeo, A. Cardenas, S. Sinha, D. Glassman, R. Nicolle, , S. D. Leach

The paper develops ATAC-Array, a low-cost chromatin accessibility assay, and shows it predicts pancreatic cancer prognosis based on chromatin accessibility patterns.

bioRxiv · Jan 21, 2021Cancer Biology